serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.355 Ethers .
D02.355.291 Ethers, Cyclic .
D02.355.291.852 Oxepins .
D02.355.291.852.500 Doxepin .
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.098 Benzylisoquinolines .
D03.132.098.038 Aporphines .
D03.132.098.038.290 Apomorphine .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.621 Piperidines .
D03.383.621.270 Flecainide .
D03.383.621.900 Trihexyphenidyl .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.531 Isoquinolines .
D03.633.100.531.085 Benzylisoquinolines .
D03.633.100.531.085.030 Aporphines .
D03.633.100.531.085.030.290 Apomorphine .
D03.633.300 Heterocyclic Compounds, 3-Ring .
D03.633.300.382 Dibenzoxepins .
D03.633.300.382.393 Doxepin .
D03.633.400 Heterocyclic Compounds, 4 or More Rings .
D03.633.400.095 Aporphines .
D03.633.400.095.290 Apomorphine .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.656 Peptide Hydrolases .
D08.811.277.656.262 Cysteine Proteases .
D08.811.277.656.262.500 Cysteine Endopeptidases .
D08.811.277.656.262.500.126 Caspases .
D08.811.277.656.262.500.126.350 Caspases, Effector .
D08.811.277.656.262.500.126.350.300 Caspase 3 .
D08.811.277.656.300 Endopeptidases .
D08.811.277.656.300.200 Cysteine Endopeptidases .
D08.811.277.656.300.200.126 Caspases .
D08.811.277.656.300.200.126.350 Caspases, Effector .
D08.811.277.656.300.200.126.350.300 Caspase 3 .
D10 Lipids .
D10.532 Lipoproteins .
D10.532.091 Apolipoproteins .
D10.532.091.200 Apolipoproteins A .
D10.532.091.400 Apolipoproteins C .
D10.532.091.400.750 Apolipoprotein C-II .
D10.532.091.500 Apolipoproteins E .
D10.532.091.500.249 Apolipoprotein E2 .
D10.532.091.500.500 Apolipoprotein E3 .
D10.532.091.500.750 Apolipoprotein E4 .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.360 Intracellular Signaling Peptides and Proteins .
D12.644.360.075 Apoptosis Regulatory Proteins .
D12.644.360.075.405 Caspases .
D12.644.360.075.405.350 Caspases, Effector .
D12.644.360.075.405.350.300 Caspase 3 .
D12.776 Proteins .
D12.776.070 Apoproteins .
D12.776.070.400 Apolipoproteins .
D12.776.070.400.200 Apolipoproteins A .
D12.776.070.400.400 Apolipoproteins C .
D12.776.070.400.400.750 Apolipoprotein C-II .
D12.776.070.400.500 Apolipoproteins E .
D12.776.070.400.500.249 Apolipoprotein E2 .
D12.776.070.400.500.500 Apolipoprotein E3 .
D12.776.070.400.500.750 Apolipoprotein E4 .
D12.776.476 Intracellular Signaling Peptides and Proteins .
D12.776.476.075 Apoptosis Regulatory Proteins .
D12.776.476.075.405 Caspases .
D12.776.476.075.405.350 Caspases, Effector .
D12.776.476.075.405.350.300 Caspase 3 .
D12.776.521 Lipoproteins .
D12.776.521.120 Apolipoproteins .
D12.776.521.120.200 Apolipoproteins A .
D12.776.521.120.400 Apolipoproteins C .
D12.776.521.120.400.750 Apolipoprotein C-II .
D12.776.521.120.500 Apolipoproteins E .
D12.776.521.120.500.249 Apolipoprotein E2 .
D12.776.521.120.500.500 Apolipoprotein E3 .
D12.776.521.120.500.750 Apolipoprotein E4 .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Apomorphine .
Apokinon .
Apomorphin-Teclapharm .
Apomorphine Chloride .
Apomorphine Hydrochloride .
Apomorphine Hydrochloride Anhydrous .
Apomorphine Hydrochloride, Anhydrous .
Apomorphine Hydrochloride, Hemihydrate .
Britaject .
Anhydrous Apomorphine Hydrochloride .
Anhydrous, Apomorphine Hydrochloride .
Apomorphin Teclapharm .
ApomorphinTeclapharm .
Chloride, Apomorphine .
Hemihydrate Apomorphine Hydrochloride .
Hydrochloride Anhydrous, Apomorphine .
Hydrochloride, Anhydrous Apomorphine .
Hydrochloride, Apomorphine .
Hydrochloride, Hemihydrate Apomorphine .
A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. .
1.00
528590
 
Doxepin .
Apo-Doxepin .
Aponal .
Deptran .
Desidox .
Doneurin .
Doxepia .
Doxepin Hydrochloride .
Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5) .
Doxepin beta .
Doxepin-RPh .
Espadox .
Mareen .
Novo-Doxepin .
Prudoxin .
Quitaxon .
Sinequan .
Sinquan .
Xepin .
Zonalon .
Apo Doxepin .
ApoDoxepin .
Doxepin RPh .
Hydrochloride, Doxepin .
Novo Doxepin .
A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. .
0.55
11798
 
Apolipoproteins A .
ApoA 825 .
Apo-A .
Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. .
0.54
443772
 
Caspase 3 .
Apopain .
Caspase-3 .
Pro-Caspase-3 .
Procaspase-3 .
Pro Caspase 3 .
Procaspase 3 .
CASP3 .
A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. .
0.50
1827382
 
Trihexyphenidyl .
Apo-Trihex .
Artane .
Cyclodol .
Hipokinon .
Parkinane .
Parkopan .
Trihexane .
Trihexidyl Hydrochloride .
Trihexyphenidyl Hydrochloride .
Trihexyphenidyl Hydrochloride Elixir .
Apo Trihex .
ApoTrihex .
Benzhexol .
One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic. .
0.50
14771
 
Apolipoprotein C-II .
Apo C-II .
ApoC2 .
Apolipoprotein C-2 .
Apolipoprotein CII .
Apoprotein C-II .
Apo C II .
Apolipoprotein C 2 .
Apolipoprotein C II .
Apoprotein C II .
A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS. It contains a cofactor for LIPOPROTEIN LIPASE and activates several triacylglycerol lipases. The association of Apo C-II with plasma CHYLOMICRONS; VLDL, and HIGH-DENSITY LIPOPROTEINS is reversible and changes rapidly as a function of triglyceride metabolism. Clinically, Apo C-II deficiency is similar to lipoprotein lipase deficiency (HYPERLIPOPROTEINEMIA TYPE I) and is therefore called hyperlipoproteinemia type IB. .
0.50
0661
 
Flecainide .
Apocard .
Flecadura .
Flecainid-Isis .
Flecainide Monoacetate .
Flecainide Monoacetate, (+-)-Isomer .
Flecainide Monoacetate, (R)-Isomer .
Flecainide Monoacetate, (S)-Isomer .
Flecainide, (R)-Isomer .
Flecainide, (S)-Isomer .
Flecainide, 5-HO-N-(6-oxo)-Derivative .
Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer .
Flecatab .
Flécaïne .
R818 18576 .
Tambocor .
Acetate, Flecainide .
Flecainid Isis .
Flecainide Acetate .
A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS. .
0.49
171581
 
Apolipoprotein E4 .
Apo E epsilon 4 .
Apo E-4 .
Apo E4 .
ApoE4 .
Apolipoprotein E-4 .
Apo E 4 .
Apolipoprotein E 4 .
A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES. .
0.49
13992
 
Apolipoprotein E2 .
APOE-epsilon 2 .
APOE-epsilon2 .
Apo E-2 .
Apo E2 .
ApoE2 .
Apolipoprotein E-2 .
Apolipoprotein E-epsilon2 .
APOE epsilon 2 .
APOE epsilon2 .
Apo E 2 .
Apolipoprotein E 2 .
Apolipoprotein E epsilon2 .
One of three major isoforms of apolipoprotein E. In humans, Apo E2 differs from APOLIPOPROTEIN E3 at one residue 158 where arginine is replaced by cysteine (R158--C). In contrast to Apo E3, Apo E2 displays extremely low binding affinity for LDL receptors (RECEPTORS, LDL) which mediate the internalization and catabolism of lipoprotein particles in liver cells. ApoE2 allelic homozygosity is associated with HYPERLIPOPROTEINEMIA TYPE III. .
0.49
0673
 
Apolipoprotein E3 .
APOE-epsilon 3 .
APOE-epsilon3 .
Apo E-3 .
Apo E3 .
ApoE3 .
Apolipoprotein E-3 .
Apolipoprotein E-epsilon3 .
Isoapolipoprotein E3 .
APOE epsilon 3 .
APOE epsilon3 .
Apo E 3 .
Apolipoprotein E 3 .
Apolipoprotein E epsilon3 .
A 34-kDa glycosylated protein. A major and most common isoform of apolipoprotein E. Therefore, it is also known as apolipoprotein E (ApoE). In human, Apo E3 is a 299-amino acid protein with a cysteine at the 112 and an arginine at the 158 position. It is involved with the transport of TRIGLYCERIDES; PHOSPHOLIPIDS; CHOLESTEROL; and CHOLESTERYL ESTERS in and out of the cells. .
0.49
0924